Global Flu Vaccine Market Research Report 2020

Global Flu Vaccine Market Research Report 2020

Table of Contents
1 Flu Vaccine Market Overview
1.1 Product Overview and Scope of Flu Vaccine
1.2 Flu Vaccine Segment by Type
1.2.1 Global Flu Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Split Influenza Vaccine
1.2.3 Pandemic Influenza Vaccine
1.2.4 Subunit Influenza Vaccine
1.2.5 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Segment by Application
1.3.1 Flu Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Flu Vaccine Revenue 2015-2026
1.4.2 Global Flu Vaccine Sales 2015-2026
1.4.3 Flu Vaccine Market Size by Region: 2020 Versus 2026
2 Global Flu Vaccine Market Competition by Manufacturers
2.1 Global Flu Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Flu Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Flu Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Flu Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Flu Vaccine Market Competitive Situation and Trends
2.5.1 Flu Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Flu Vaccine Players (Opinion Leaders)
3 Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Flu Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Flu Vaccine Market Facts & Figures by Country
3.3.1 North America Flu Vaccine Sales by Country
3.3.2 North America Flu Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Flu Vaccine Market Facts & Figures by Country
3.4.1 Europe Flu Vaccine Sales by Country
3.4.2 Europe Flu Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Flu Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Flu Vaccine Sales by Region
3.5.2 Asia Pacific Flu Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Flu Vaccine Market Facts & Figures by Country
3.6.1 Latin America Flu Vaccine Sales by Country
3.6.2 Latin America Flu Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Flu Vaccine Sales by Country
3.7.2 Middle East and Africa Flu Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Flu Vaccine Historic Market Analysis by Type
4.1 Global Flu Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Flu Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Flu Vaccine Price Market Share by Type (2015-2020)
4.4 Global Flu Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Flu Vaccine Historic Market Analysis by Application
5.1 Global Flu Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Flu Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Flu Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Flu Vaccine Business
6.1 Hualan Bio
6.1.1 Corporation Information
6.1.2 Hualan Bio Description, Business Overview and Total Revenue
6.1.3 Hualan Bio Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Hualan Bio Products Offered
6.1.5 Hualan Bio Recent Development
6.2 CCBIO
6.2.1 CCBIO Flu Vaccine Production Sites and Area Served
6.2.2 CCBIO Description, Business Overview and Total Revenue
6.2.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CCBIO Products Offered
6.2.5 CCBIO Recent Development
6.3 Aleph Biomedical
6.3.1 Aleph Biomedical Flu Vaccine Production Sites and Area Served
6.3.2 Aleph Biomedical Description, Business Overview and Total Revenue
6.3.3 Aleph Biomedical Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Aleph Biomedical Products Offered
6.3.5 Aleph Biomedical Recent Development
6.4 SANOFI
6.4.1 SANOFI Flu Vaccine Production Sites and Area Served
6.4.2 SANOFI Description, Business Overview and Total Revenue
6.4.3 SANOFI Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SANOFI Products Offered
6.4.5 SANOFI Recent Development
6.5 Adimmune
6.5.1 Adimmune Flu Vaccine Production Sites and Area Served
6.5.2 Adimmune Description, Business Overview and Total Revenue
6.5.3 Adimmune Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Adimmune Products Offered
6.5.5 Adimmune Recent Development
6.6 ZYAK
6.6.1 ZYAK Flu Vaccine Production Sites and Area Served
6.6.2 ZYAK Description, Business Overview and Total Revenue
6.6.3 ZYAK Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 ZYAK Products Offered
6.6.5 ZYAK Recent Development
6.7 SINOVAC
6.6.1 SINOVAC Flu Vaccine Production Sites and Area Served
6.6.2 SINOVAC Description, Business Overview and Total Revenue
6.6.3 SINOVAC Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SINOVAC Products Offered
6.7.5 SINOVAC Recent Development
6.8 Changsheng Biological
6.8.1 Changsheng Biological Flu Vaccine Production Sites and Area Served
6.8.2 Changsheng Biological Description, Business Overview and Total Revenue
6.8.3 Changsheng Biological Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Changsheng Biological Products Offered
6.8.5 Changsheng Biological Recent Development
6.9 SIOBP
6.9.1 SIOBP Flu Vaccine Production Sites and Area Served
6.9.2 SIOBP Description, Business Overview and Total Revenue
6.9.3 SIOBP Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 SIOBP Products Offered
6.9.5 SIOBP Recent Development
6.10 GSK
6.10.1 GSK Flu Vaccine Production Sites and Area Served
6.10.2 GSK Description, Business Overview and Total Revenue
6.10.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 GSK Products Offered
6.10.5 GSK Recent Development
6.11 Aimei Hissen
6.11.1 Aimei Hissen Flu Vaccine Production Sites and Area Served
6.11.2 Aimei Hissen Flu Vaccine Description, Business Overview and Total Revenue
6.11.3 Aimei Hissen Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Aimei Hissen Products Offered
6.11.5 Aimei Hissen Recent Development
6.12 Tianyuan Bio-pharma(Novartis)
6.12.1 Tianyuan Bio-pharma(Novartis) Flu Vaccine Production Sites and Area Served
6.12.2 Tianyuan Bio-pharma(Novartis) Flu Vaccine Description, Business Overview and Total Revenue
6.12.3 Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Tianyuan Bio-pharma(Novartis) Products Offered
6.12.5 Tianyuan Bio-pharma(Novartis) Recent Development
6.13 Simcere Vaxtec
6.13.1 Simcere Vaxtec Flu Vaccine Production Sites and Area Served
6.13.2 Simcere Vaxtec Flu Vaccine Description, Business Overview and Total Revenue
6.13.3 Simcere Vaxtec Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Simcere Vaxtec Products Offered
6.13.5 Simcere Vaxtec Recent Development
7 Flu Vaccine Manufacturing Cost Analysis
7.1 Flu Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Flu Vaccine
7.4 Flu Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Flu Vaccine Distributors List
8.3 Flu Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Flu Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Flu Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Flu Vaccine by Type (2021-2026)
10.2 Flu Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Flu Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Flu Vaccine by Application (2021-2026)
10.3 Flu Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Flu Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Flu Vaccine by Region (2021-2026)
10.4 North America Flu Vaccine Estimates and Projections (2021-2026)
10.5 Europe Flu Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Flu Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Flu Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Flu Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Flu Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Flu Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Flu Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Flu Vaccine Manufacturers Covered in This Study
Table 5. Global Flu Vaccine Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Flu Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Flu Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Flu Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Flu Vaccine Average Price (USD/Doses) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Flu Vaccine Sales Sites and Area Served
Table 11. Manufacturers Flu Vaccine Product Types
Table 12. Global Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu Vaccine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Flu Vaccine Players
Table 16. Global Flu Vaccine Sales (K Doses) by Region (2015-2020)
Table 17. Global Flu Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Flu Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Flu Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Flu Vaccine Sales by Country (2015-2020) (K Doses)
Table 21. North America Flu Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Flu Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Flu Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Flu Vaccine Sales by Country (2015-2020) (K Doses)
Table 25. Europe Flu Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Flu Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Flu Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Flu Vaccine Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Flu Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Flu Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Flu Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Flu Vaccine Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Flu Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Flu Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Flu Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Flu Vaccine Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Flu Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Flu Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Flu Vaccine Sales (K Doses) by Type (2015-2020)
Table 41. Global Flu Vaccine Sales Share by Type (2015-2020)
Table 42. Global Flu Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Flu Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Flu Vaccine Price (USD/Doses) by Type (2015-2020)
Table 45. Global Flu Vaccine Sales (K Doses) by Application (2015-2020)
Table 46. Global Flu Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Flu Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Hualan Bio Flu Vaccine Corporation Information
Table 49. Hualan Bio Description and Business Overview
Table 50. Hualan Bio Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 51. Hualan Bio Main Product
Table 52. Hualan Bio Recent Development
Table 53. CCBIO Flu Vaccine Corporation Information
Table 54. CCBIO Corporation Information
Table 55. CCBIO Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 56. CCBIO Main Product
Table 57. CCBIO Recent Development
Table 58. Aleph Biomedical Flu Vaccine Corporation Information
Table 59. Aleph Biomedical Corporation Information
Table 60. Aleph Biomedical Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 61. Aleph Biomedical Main Product
Table 62. Aleph Biomedical Recent Development
Table 63. SANOFI Flu Vaccine Corporation Information
Table 64. SANOFI Corporation Information
Table 65. SANOFI Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 66. SANOFI Main Product
Table 67. SANOFI Recent Development
Table 68. Adimmune Flu Vaccine Corporation Information
Table 69. Adimmune Corporation Information
Table 70. Adimmune Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 71. Adimmune Main Product
Table 72. Adimmune Recent Development
Table 73. ZYAK Flu Vaccine Corporation Information
Table 74. ZYAK Corporation Information
Table 75. ZYAK Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 76. ZYAK Main Product
Table 77. ZYAK Recent Development
Table 78. SINOVAC Flu Vaccine Corporation Information
Table 79. SINOVAC Corporation Information
Table 80. SINOVAC Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 81. SINOVAC Main Product
Table 82. SINOVAC Recent Development
Table 83. Changsheng Biological Flu Vaccine Corporation Information
Table 84. Changsheng Biological Corporation Information
Table 85. Changsheng Biological Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 86. Changsheng Biological Main Product
Table 87. Changsheng Biological Recent Development
Table 88. SIOBP Flu Vaccine Corporation Information
Table 89. SIOBP Corporation Information
Table 90. SIOBP Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 91. SIOBP Main Product
Table 92. SIOBP Recent Development
Table 93. GSK Flu Vaccine Corporation Information
Table 94. GSK Corporation Information
Table 95. GSK Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 96. GSK Main Product
Table 97. GSK Recent Development
Table 98. Aimei Hissen Flu Vaccine Corporation Information
Table 99. Aimei Hissen Corporation Information
Table 100. Aimei Hissen Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 101. Aimei Hissen Main Product
Table 102. Aimei Hissen Recent Development
Table 103. Tianyuan Bio-pharma(Novartis) Flu Vaccine Corporation Information
Table 104. Tianyuan Bio-pharma(Novartis) Corporation Information
Table 105. Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 106. Tianyuan Bio-pharma(Novartis) Main Product
Table 107. Tianyuan Bio-pharma(Novartis) Recent Development
Table 108. Simcere Vaxtec Flu Vaccine Corporation Information
Table 109. Simcere Vaxtec Corporation Information
Table 110. Simcere Vaxtec Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 111. Simcere Vaxtec Main Product
Table 112. Simcere Vaxtec Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Flu Vaccine Distributors List
Table 116. Flu Vaccine Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Flu Vaccine Sales (K Doses) Forecast by Type (2021-2026)
Table 121. Global Flu Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Flu Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Flu Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Flu Vaccine Sales (K Doses) Forecast by Application (2021-2026)
Table 125. Global Flu Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Flu Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 127. Global Flu Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Flu Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Flu Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Flu Vaccine
Figure 2. Global Flu Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Split Influenza Vaccine Product Picture
Figure 4. Pandemic Influenza Vaccine Product Picture
Figure 5. Subunit Influenza Vaccine Product Picture
Figure 6. Quadrivalent Influenza Vaccine Product Picture
Figure 7. Global Flu Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 8. For Children (6 months to 3 years)
Figure 9. For Adults and Children over 3 years
Figure 10. Global Flu Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Flu Vaccine Sales Capacity (K Doses) (2015-2026)
Figure 12. Global Flu Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Flu Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Flu Vaccine Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Flu Vaccine Revenue in 2019
Figure 16. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Flu Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Flu Vaccine Sales Market Share by Region in 2019
Figure 19. Global Flu Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Flu Vaccine Revenue Market Share by Region in 2019
Figure 21. North America Flu Vaccine Sales Market Share by Country in 2019
Figure 22. North America Flu Vaccine Revenue Market Share by Country in 2019
Figure 23. U.S. Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 24. U.S. Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 26. Canada Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Flu Vaccine Sales Market Share by Country in 2019
Figure 28. Europe Flu Vaccine Revenue Market Share by Country in 2019
Figure 29. Germany Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 30. Germany Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 32. France Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.K. Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Italy Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Russia Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Flu Vaccine Sales Market Share by Region in 2019
Figure 40. Asia Pacific Flu Vaccine Revenue Market Share by Region in 2019
Figure 41. China Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 42. China Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Japan Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. South Korea Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 48. India Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Australia Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Taiwan Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Indonesia Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Thailand Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Malaysia Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 60. Philippines Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Vietnam Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Flu Vaccine Sales Market Share by Country in 2019
Figure 64. Latin America Flu Vaccine Revenue Market Share by Country in 2019
Figure 65. Mexico Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. Mexico Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Brazil Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Flu Vaccine Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Flu Vaccine Revenue Market Share by Country in 2019
Figure 73. Turkey Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Turkey Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Saudi Arabia Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Flu Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. U.A.E Flu Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Flu Vaccine by Type (2015-2020)
Figure 80. Sales Market Share of Flu Vaccine by Type in 2019
Figure 81. Revenue Share of Flu Vaccine by Type (2015-2020)
Figure 82. Revenue Market Share of Flu Vaccine by Type in 2019
Figure 83. Global Flu Vaccine Sales Growth by Type (2015-2020) (K Doses)
Figure 84. Global Flu Vaccine Sales Market Share by Application (2015-2020)
Figure 85. Global Flu Vaccine Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Flu Vaccine by Application (2015-2020)
Figure 87. Global Revenue Share of Flu Vaccine by Application in 2020
Figure 88. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. CCBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Aleph Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. SANOFI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Adimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. ZYAK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. SINOVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Changsheng Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. SIOBP Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Aimei Hissen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Tianyuan Bio-pharma(Novartis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Simcere Vaxtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Flu Vaccine
Figure 103. Manufacturing Process Analysis of Flu Vaccine
Figure 104. Flu Vaccine Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 109. North America Flu Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Flu Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Flu Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Flu Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Flu Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Flu Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs